Filing Flows › cbdMD (YCBD) › Q2 FY26 › vs Q1 FY26
cbdMD (YCBD) Q2 FY26 vs Q1 FY26 (quarter over quarter)
cbdMD's revenue rose $623K (+12%) from $5.0M in Q1 FY26 to $5.6M in Q2 FY26.
cbdMD, Q2 FY26: revenue $5.6M (+19% year over year), operating margin -14.2%, net loss $798K, operating cash flow −$722K. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q2 FY26 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $5.6M | $5.0M | $623K | +12% |
| Net loss | $798K | $283K | $515K | +182% |
| Costs & expenses | $6.4M | $5.3M | $1.1M | +21% |
| Operating costs | $6.4M | $5.3M | $1.1M | +21% |
| Cost of revenue | $2.4M | $2.0M | $368K | +18% |
| Operating expenses | $4.1M | $3.3M | $770K | +23% |
| Operating cash sources | $974K | $1.1M | −$84K | -8% |
| Depreciation & amortization | $252K | $245K | $6K | +2% |
| Cash used in operations | $722K | $812K | −$90K | -11% |
| Net loss absorbed | $798K | $283K | $515K | +182% |
| Working capital & other | $176K | $775K | −$599K | -77% |
Questions
How much did cbdMD's revenue grow quarter over quarter in Q2 FY26?
cbdMD's revenue rose $623K (+12%) from $5.0M in Q1 FY26 to $5.6M in Q2 FY26.